Learn more →
Back to Expert Scholars
clinical / clinicalPediatric Oncology

Cynthia Wetmore

辛西娅·韦特莫尔

MD, PhD

🏢Children's Hospital Colorado / University of Colorado School of Medicine(科罗拉多儿童医院/科罗拉多大学医学院)🌐USA

Section Chief, Pediatric Neuro-Oncology; Professor of Pediatrics儿童神经肿瘤科主任;儿科学教授

38
h-index
3
Key Papers
5
Awards
3
Key Contributions

👥Biography 个人简介

Cynthia Wetmore is a leading pediatric neuro-oncologist at Children's Hospital Colorado who serves as a principal investigator for multiple Children's Oncology Group ACNS trials, focuses on reducing treatment-related neurotoxicity in pediatric brain tumor survivors, and pioneers molecular approaches to low-grade glioma management.

Share:

🧪Research Fields 研究领域

Pediatric Neuro-Oncology儿童神经肿瘤学
ACNS Consortium TrialsACNS联盟临床试验
Pediatric Glioma儿童胶质瘤
Neurologic Late Effects神经系统远期效应

🎓Key Contributions 主要贡献

COG ACNS Clinical Trials Leadership

Serves as principal investigator on multiple COG ACNS consortium trials including ACNS1422 (BRAF-inhibitor LGG trial) and ACNS1833, advancing evidence-based standard of care.

Pediatric Low-Grade Glioma Management

Led studies establishing BRAF fusion and BRAF V600E mutation testing as standard for pediatric LGG, enabling targeted therapy with MEK/BRAF inhibitors as first-line treatment.

Neurocognitive Late Effects Research

Conducted prospective studies quantifying neurocognitive decline after cranial radiation in pediatric brain tumor patients, informing risk-adapted approaches to minimize long-term sequelae.

Representative Works 代表性著作

[1]

BRAF inhibition in pediatric low-grade glioma: ACNS1422 phase II results

Journal of Clinical Oncology (2023)

Phase II results demonstrating superior response rate of dabrafenib/trametinib versus chemotherapy in BRAF V600E-mutant pediatric LGG.

[2]

Neurocognitive outcomes in pediatric brain tumor survivors treated with proton versus photon therapy

Neuro-Oncology (2021)

Prospective comparison showing neurocognitive advantages of proton therapy in pediatric brain tumor treatment.

[3]

Molecular classification and therapeutic targets in pediatric low-grade glioma

Cancer Research (2019)

Comprehensive genomic characterization of pediatric LGG establishing BRAF, FGFR, and MYB alterations as actionable targets.

🏆Awards & Recognition 奖项与荣誉

🏆Children's Hospital Colorado Researcher of the Year
🏆COG ACNS Disease Committee Leadership Award
🏆ASPHO Presidential Award
🏆PBTF Clinical Research Award
🏆University of Colorado Excellence in Mentorship Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 辛西娅·韦特莫尔 的研究动态

Follow Cynthia Wetmore's research updates

留下邮箱,当我们发布与 Cynthia Wetmore(Children's Hospital Colorado / University of Colorado School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment